The specific delivery of proteins to human liver cells by engineered bio-nanocapsules

FEBS Journal

Volumn 272, Issue 14, 2005, Pages 3651-3660

  Yu, Dongwei ^a   Amano, Chie ^a   Fukuda, Takayuki ^a,b   Yamada, Tadanori ^c   Kuroda, Shun'ichi ^c,d   Tanizawa, Katsuyuki ^c,d   Kondo, Akihiko ^d,e   Ueda, Masakazu ^d,f   Yamada, Hidenori ^a   Tada, Hiroko ^a   Seno, Masaharu ^a,d  

^a OKAYAMA UNIVERSITY   (Japan)

^b Kobe R and D Center   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Beacle Inc   (Japan)

^e KOBE UNIVERSITY   (Japan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Bio nanocapsule; L fusion protein; Protein delivery vector; Specific infection; Topology

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; CYTOPLASM PROTEIN; EMERALD GREEN FLUORESCENT PROTEIN; GLYCINE CLEAVAGE SYSTEM; HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; NANOCAPSULE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOENGINEERING; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS7; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; LIVER CELL; MODEL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; ANIMALS; BIOTECHNOLOGY; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 22544483530     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04790.x     Document Type: Article

References (27)

1. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H & Gerlich WH (1984) Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 52, 396-402.
2. Valenzuela P, Medina A, Rutter WJ, Ammerer G & Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298, 347-350.
3. Kuroda S, Otaka S, Miyazaki T, Nakao M & Fujisawa Y (1992) Hepatitis B virus envelope L protein particles, synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem 267, 1953-1961.
4. Fujisawa Y, Kuroda S, Van Herd PM, Schellekens H & Kakinuma A (1990) Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). Vaccine 8, 192-198.
5. Yamada T, Iwabuki H, Kanno T, Tanaka H, Kawai T, Fukuda H, Kondo A, Seno M, Tanizawa K & Kuroda S (2001) Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine 19, 3154-3163.
6. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M et al. (2003) Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 21, 885-890.
7. Marion PL, Salazar FH, Alexander JJ & Robinson WS (1979) Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell line. J Virol 32, 796-802.
8. Neurath AR, Kent SB, Strick N & Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.
9. Neurath AR & Kent SB (1988) The pre-S region of hepadnavirus envelope proteins. Adv Virus Res 34, 65-142.
10. Guerrero E, Gavilanes F & Peterson DL (1988) Model for the Protein Arrangement in Hbsag Particles Based on Physical and Chemical Studies, in Viral Hepatitis and Liver Disease (Zuckerman AJ, ed.), pp. 606-613. Alan R. Liss, New York.
11. Strik HJ, Thornton JM & Howard CR (1992) A topological model for hepatitis B surface antigen. Intervirology 33, 148-158.
12. Eble BE, MacRae DR, Lingappa VR & Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 7, 3591-3601.
13. Bruss V & Ganem D (1991) Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol 65, 3813-3820.
14. Prange R, Nagel R & Streeck RE (1992) Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J Virol 66, 5832-5841.
15. Bruss V, Gerhardt E, Vieluf K & Wunderlich G (1996) Functions of the large hepatitis B virus surface protein in viral particle morphagenesis. Intervirology 39, 23-31.
16. Eble BE, Lingappa VR & Ganem D (1990) The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J Virol 64, 1414-1419.
17. Sureau C, Fournier-Wirth C & Maurel P (2003) Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus. J Virol 77, 5519-5523.
18. Berting A, Hahnen J, Kroger M & Gerlich WH (1995) Computer-aided studies on the spatial structure of the small hepatitis B surface protein. Intervirology 38, 8-15.
19. Yang F, Moss LG & Phillips GN Jr (1996) The molecular structure of green fluorescent protein. Nat Biotechnol 14, 1246-1251.
20. Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY & Remington SJ (1996) Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392-1395.
21. Kennedy RC, Ionescu-Matiu I, Adler-Storthz K, Henkel RD, Sanchez Y & Dreesman GR (1983) Characterization of anti-hepatitis B surface antigen monoclonal antibodies. Intervirology 19, 176-180.
22. Zuckerman JN & Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60, 75-78.
23. Paulij WP, de Wit PL, Sunnen CM, van Roosmalen MH, Petersen-van Ettekoven A, Cooreman MP & Heijtink RA (1999) Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J Gen Virol 80, 2121-2126.
24. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C & Gripon P (1999) Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-Sl domain. J Virol 73, 2052-2057.
25. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W & Thomas HC (1992) Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 90, 2543-2547.
26. Cooreman MP, van Roosmalen MH, te Morsche R, Sunnen CM, de Yen EM, Jansen JB, Tytgat GN, de Wit PL & Paulij WP (1999) Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring 'a' loop escape mutations. Hepatology 30, 1287-1292.
27. Tada H, Kurokawa T, Seita T, Watanabe T & Iwasa S (1994) Expression and characterization of a chimeric bispecific antibody against fibrin and against urokinase-type plasminogen activator. J Biotechnol 33, 157-174.